Bank of New York Mellon
OGEN icon

Bank of New York Mellon’s Oragenics OGEN Stock Holding History

Bank of New York Mellon’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11
Closed -$12K – 4134
2020
Q1 		$12K Hold
11
– – ﹤0.01% 4080
2019
Q4 		$10K Hold
11
– – ﹤0.01% 4170
2019
Q3 		$11K Hold
11
– – ﹤0.01% 4204
2019
Q2 		$10K Hold
11
– – ﹤0.01% 4203
2019
Q1 		$12K Hold
11
– – ﹤0.01% 4187
2018
Q4 		$17K Hold
11
– – ﹤0.01% 4173
2018
Q3 		$23K Hold
11
– – ﹤0.01% 4200
2018
Q2 		$28K Hold
11
– – ﹤0.01% 4150
2018
Q1 		$36K Hold
11
– – ﹤0.01% 4214
2017
Q4 		$47K Hold
11
– – ﹤0.01% 4212
2017
Q3 		$84K Buy
+11
New +$72.7K ﹤0.01% 4029

Other funds holding OGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SBF
Sara-Bay Financial Sarasota, Florida $375M AUM 56.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon's OGEN Position: Q2 2020 in Review

Bank of New York Mellon sold out of Oragenics (OGEN) in Q2 2020, closing a stake of 11 shares — an estimated $12K sold.

Bank of New York Mellon first reported a position in OGEN in Q3 2017 and held it in 11 quarters. The position peaked at $84K in Q3 2017. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2020.

  • Bank of New York Mellon reported no remaining Oragenics position as of Q2 2020 after selling out during the quarter.
  • Bank of New York Mellon sold 11 Oragenics shares in Q2 2020, an estimated $12K.
  • Bank of New York Mellon first reported a position in Oragenics in Q3 2017 and held it in 11 quarters.
  • Bank of New York Mellon's Oragenics position peaked at $84K in Q3 2017.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q2 2020.

Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.